Bernard Tawfik

697 total citations
30 papers, 335 citations indexed

About

Bernard Tawfik is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Bernard Tawfik has authored 30 papers receiving a total of 335 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 5 papers in Epidemiology. Recurrent topics in Bernard Tawfik's work include Brain Metastases and Treatment (3 papers), Advanced Breast Cancer Therapies (3 papers) and Neuroendocrine Tumor Research Advances (3 papers). Bernard Tawfik is often cited by papers focused on Brain Metastases and Treatment (3 papers), Advanced Breast Cancer Therapies (3 papers) and Neuroendocrine Tumor Research Advances (3 papers). Bernard Tawfik collaborates with scholars based in United States, Puerto Rico and South Africa. Bernard Tawfik's co-authors include Bärry Benisch, Timothy S. Pardee, Scott Isom, Heidi D. Klepin, Bayard L. Powell, Julia Lawrence, Sergio Huerta, Ali A. Mokdad, Allison Winter and Leslie R. Ellis and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Journal of Applied Physiology.

In The Last Decade

Bernard Tawfik

26 papers receiving 318 citations

Peers

Countries citing papers authored by Bernard Tawfik

Since Specialization

Citations

This map shows the geographic impact of Bernard Tawfik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernard Tawfik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernard Tawfik more than expected).

Fields of papers citing papers by Bernard Tawfik

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernard Tawfik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernard Tawfik. The network helps show where Bernard Tawfik may publish in the future.

Co-authorship network of co-authors of Bernard Tawfik

This figure shows the co-authorship network connecting the top 25 collaborators of Bernard Tawfik. A scholar is included among the top collaborators of Bernard Tawfik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernard Tawfik. Bernard Tawfik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Melanoma Brain Metastasis CTC Signature and CTC:B-cell Clusters Associate with Secondary Liver Metastasis: A Melanoma Brain–Liver Metastasis Axis 2025 ·Cancer Research Communications ·(unknown), (unknown), Irina V. Lagutina, Mara P. Steinkamp, Bridget N. Fahy, Bernard Tawfik, (unknown), Dario Marchetti	3
2	Addressing Challenges in Research Aimed at Reducing Financial Toxicity Among Cancer Patients and Caregivers: An Example From the CREDIT Study (SWOG S1912CD) 2025 ·Cancer Control ·(unknown), Bernard Tawfik, (unknown), (unknown), Kate Watabayashi, (unknown), Ruth C. Carlos, Shelby L. Langer, (unknown), Amy K. Darke, Dawn L. Hershman, Scott D. Ramsey, Veena Shankaran	1
3	Palbociclib in patients (pts) with ovarian cancer (OC) with CDKN2A alterations: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) study. 2025 ·Journal of Clinical Oncology ·Dan S. Veljovich, Michael Rothe, Pam K. Mangat, Elizabeth Garrett‐Mayer, (unknown), R. Wendel Naumann, Jean Siedel, John K. Chan, Andrew Gregory, Evan Pisick, Bamidele Adesunloye, Rebecca C. Arend, Maria C. Bell, Marina Frimer, Bernard Tawfik, Ramya Thota, Apostolia M. Tsimberidou, (unknown), Susan Halabi, Richard L. Schilsky	0
4	Randomized pilot trial of an unconditional cash transfer intervention to address food insecurity in oncology 2024 ·JNCI Cancer Spectrum ·Jean A. McDougall, (unknown), (unknown), (unknown), Joyce A. Wilson, (unknown), Tawny W. Boyce, Bernard Tawfik, Janet Page‐Reeves	0
5	Developing questions to assess and measure patients’ perceived survival benefit from adjuvant endocrine therapy in breast cancer: a mixed methods pilot study 2024 ·Clinical and Experimental Medicine ·Bernard Tawfik, (unknown), Ursa Brown‐Glaberman, (unknown), M. Lee Van Horn, (unknown), Zoneddy Dayao, V. Shane Pankratz, Andrew L. Sussman, Dolores D. Guest	0
6	Targeting Translation and the Cell Cycle Inversely Affects CTC Metabolism but Not Metastasis 2023 ·Cancers ·(unknown), Seth D. Merkley, Irina V. Lagutina, (unknown), Margaret Lee, Bernard Tawfik, Dario Marchetti	3
7	A pilot randomized, placebo-controlled, double-blind study of omega-3 fatty acids to prevent paclitaxel-associated acute pain syndrome in breast cancer patients: Alliance A22_Pilot2 2023 ·Supportive Care in Cancer ·Bernard Tawfik, Zoneddy Dayao, Ursa Brown‐Glaberman, V. Shane Pankratz, Jacqueline M. Lafky, Charles L. Loprinzi, Debra L. Barton	7
8	The RPL/RPS Gene Signature of Melanoma CTCs Associates with Brain Metastasis 2022 ·Cancer Research Communications ·(unknown), Irina V. Lagutina, (unknown), (unknown), Reed Selwyn, Erik N. Taylor, Yan Guo, Bridget N. Fahy, Bernard Tawfik, Dario Marchetti	16
9	Reaching the “Hard-to-Reach” Sexual and Gender Diverse Communities for Population-Based Research in Cancer Prevention and Control: Methods for Online Survey Data Collection and Management 2022 ·Frontiers in Oncology ·(unknown), (unknown), (unknown), V. Shane Pankratz, Bernard Tawfik, (unknown), (unknown), Shiraz I. Mishra, Miria Kano, Purnima Madhivanan, Prajakta Adsul	8
10	Examining differences based on gender and sexual orientation for cervical cancer screening and prevention behaviors. 2022 ·Journal of Clinical Oncology ·Prajakta Adsul, (unknown), (unknown), (unknown), Bernard Tawfik, Emily Wu, (unknown), Shane Pankratz, Shiraz I. Mishra, Uma S. Nair, (unknown), Purnima Madhivanan, Miria Kano	0
11	Developing a survivorship care plan (SCP) delivery process for patients and primary care providers serving poor, rural, and minority patients with cancer 2021 ·Supportive Care in Cancer ·Bernard Tawfik, (unknown), (unknown), (unknown), Inigo San Gil, (unknown), Suzanne Gagnon, Miria Kano, (unknown), (unknown), (unknown), Charles L. Wiggins, Andrew L. Sussman, Zoneddy Dayao	7
12	Using big data to gauge effectiveness of breast cancer awareness month 2021 ·Preventive Medicine ·(unknown), V. Shane Pankratz, (unknown), Bernard Tawfik	6
13	Cost of treatment change among patients with neuroendocrine tumors (NET) treated originally with somatostatin analogs. 2021 ·Journal of Clinical Oncology ·Bernard Tawfik, (unknown), (unknown), Nicole Princic	1
14	Utility and proposed algorithm of CSF flow cytometry in hematologic malignancies 2018 ·Annals of Hematology ·Bernard Tawfik, L. Steven Brown, (unknown), Weina Chen, (unknown), (unknown), Navid Sadeghi	7
15	Phase II trial of ribociclib and everolimus in p16 low anaplastic thyroid cancer (ATC). 2017 ·Journal of Clinical Oncology ·Bernard Tawfik, David E. Gerber, Barbara Burtness, Randall Hughes, Larry L. Myers, Baran D. Sumer, John M. Truelson, Tobin J. Strom, (unknown), (unknown), (unknown), Hong Zhu, Saad A. Khan	1
16	Ischemic stroke in a patient with moderate to severe inherited factor VII deficiency 2016 ·Transfusion and Apheresis Science ·(unknown), Bernard Tawfik, (unknown), Sean G. Yates, (unknown), Sandra L. Hofmann, (unknown), Ravi Sarode	2
17	The neutrophil to albumin ratio as a predictor of pathological complete response in rectal cancer patients following neoadjuvant chemoradiation 2016 ·Anti-Cancer Drugs ·Bernard Tawfik, Ali A. Mokdad, (unknown), (unknown), Sergio Huerta	42
18	House Officer–Driven Reduction in Laboratory Utilization 2016 ·Southern Medical Journal ·Bernard Tawfik, (unknown), Nora F. Fino, David P. Miller	10
19	Comorbidity, age, and mortality among adults treated intensively for acute myeloid leukemia (AML) 2015 ·Journal of Geriatric Oncology ·Bernard Tawfik, Timothy S. Pardee, Scott Isom, (unknown), Allison Winter, Julia Lawrence, Bayard L. Powell, Heidi D. Klepin	50
20	Efficacy of the hypomethylating agents as frontline, salvage, or consolidation therapy in adults with acute myeloid leukemia (AML) 2013 ·Annals of Hematology ·Bernard Tawfik, (unknown), Susan Lyerly, Heidi D. Klepin, Julia Lawrence, Scott Isom, Leslie R. Ellis, Megan Manuel, Sarah Dralle, Dmitriy Berenzon, Bayard L. Powell, Timothy S. Pardee	46

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact